• Profile
Close
Dr. vishal bodh 1 1696419521
Dr. Vishal Bodh
Associate Professor, Department of Gastroenterology at AIMSS, Shimla, Himachal Pradesh

Dr. Vishal Bodh is an Associate Professor at the Department of Gastroenterology at Atal Institute of Medical Super-Speciality (AIMSS), Shimla, Himachal Pradesh.

MIP: Endoscopic Evaluation in Upper GI Bleeding: Dr Vishal Bodh
Watch Dr. Vishal emphasise the importance ... more»Watch Dr. Vishal emphasise the importance of endoscopy in managing upper gastrointestinal bleeding. He illuminates the latest recommendations from the Indian Society of Gastroenterology and the American College of Gastroenterology, highlighting endoscopy's pivotal role in diagnosis and treatment. «less

By Vishal Bodh | Mar 18, 2024

MIP- Bloating and Distention: AGA Guideline Updates- Dr Vishal Bodh
Watch Dr Vishal Bodh as he explains functi... more»Watch Dr Vishal Bodh as he explains functional bloating and distension in detail. He also speaks about its prevalence, diagnosis, presumptive causes for it and the diagnostic and treatment algorithms. «less

By Vishal Bodh | Dec 17, 2023

MIP: NAFLD or MAFLD?- Demystifying this Controversy: Dr Vishal Bodh
Watch Dr Vishal Bodh as he explores NAFLD ... more»Watch Dr Vishal Bodh as he explores NAFLD with the rationale for NAFLD opposition along with the emergence of MAFLD and its oppositions. He also elaborates on new terminology from Delphi consensus. «less

By Vishal Bodh | Nov 30, 2023

MIP: Recent Advances in Management of Achalasia: Dr Vishal Bodh
Watch Dr. Vishal Bodh discuss recent advan... more»Watch Dr. Vishal Bodh discuss recent advances in the management of achalasia. He covers key aspects such as diagnosis, classification, pathophysiology, and treatment modalities related to this condition. «less

By Vishal Bodh | Oct 09, 2023

The article delves into nonalcoholic fatty... more»The article delves into nonalcoholic fatty liver disease (NAFLD), detailing its definition, epidemiological trends, histological progression, and contemporary management approaches encompassing lifestyle modifications and pharmacotherapy. «less
Feb 28, 2024
This article highlights the promise of imm... more»This article highlights the promise of immunotherapy in treating a subset of colorectal cancers (dMMR/MSI-H), explaining how immune checkpoint inhibitors like PD-1 blockers have shown efficacy. «less
Dec 27, 2023
The article discusses the challenges in tr... more»The article discusses the challenges in treating chronic hepatitis B, the limitations of current therapies, and potential new approaches including immunotherapy, and therapeutic vaccines, all aimed at achieving a functional cure for the disease. «less
Oct 25, 2023
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay